Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
09 03 2021
Historique:
received: 07 05 2019
accepted: 20 01 2021
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 1 6 2021
Statut: ppublish

Résumé

The high-specific-activity factor IX (FIX) variant Padua (R338L) is the most promising transgene for hemophilia B (HB) gene therapy. Although R338 is strongly conserved in mammalian evolution, amino acid substitutions at this position are underrepresented in HB databases. We therefore undertook a complete 20 amino acid scan and determined the specific activity of human (h) and canine (c) FIX variants with every amino acid substituted at position 338. Notably, we observe that hFIX-R338L is the most active variant and cFIX-R338L is sevenfold higher than wild-type (WT) cFIX. This is consistent with the previous identification of hFIX-R338L as a cause of a rare X-linked thrombophilia risk factor. Moreover, WT hFIX and cFIX are some of the least active variants. We confirmed the increased specific activity relative to FIX-WT in vivo of a new variant, cFIX-R338I, after gene therapy in an HB dog. Last, we screened 232 pediatric subjects with thromboembolic disease without identifying F9 R338 variants. Together these observations suggest a surprising evolutionary pressure to limit FIX activity with WT FIX rather than maximize FIX activity.

Identifiants

pubmed: 33656538
pii: S2473-9529(21)00160-9
doi: 10.1182/bloodadvances.2019000405
pmc: PMC7948292
doi:

Substances chimiques

Factor IX 9001-28-9

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1324-1332

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL140078
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL064190
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL139420
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL142012
Pays : United States

Informations de copyright

© 2021 by The American Society of Hematology.

Références

Blood Adv. 2018 Mar 13;2(5):505-508
pubmed: 29500218
Haemophilia. 2015 Jul;21(4):e317-21
pubmed: 25981983
Haematologica. 2020 Feb 20;106(1):264-268
pubmed: 32079698
Biochemistry. 2005 Mar 8;44(9):3615-25
pubmed: 15736971
Pediatrics. 2009 Oct;124(4):1001-8
pubmed: 19736261
Mol Ther. 2010 Jul;18(7):1318-29
pubmed: 20424599
J Biol Chem. 1998 May 15;273(20):12089-94
pubmed: 9575152
Hum Gene Ther. 2015 Feb;26(2):69-81
pubmed: 25419787
N Engl J Med. 2017 Dec 7;377(23):2215-2227
pubmed: 29211678
Mol Ther. 2014 Mar;22(3):567-574
pubmed: 23941813
J Thromb Haemost. 2013 Jul;11(7):1329-40
pubmed: 23617593
Blood. 2017 Apr 20;129(16):2303-2307
pubmed: 28196793
Mol Ther Methods Clin Dev. 2018 Dec 31;12:184-201
pubmed: 30705923
Mol Ther. 2018 Jan 3;26(1):14-16
pubmed: 29274719
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):1-9
pubmed: 27913455
Haematologica. 2005 May;90(5):635-42
pubmed: 15921378
J Thromb Haemost. 2016 May;14(5):894-905
pubmed: 26924758
Thromb Haemost. 2013 Apr;109(4):755-6
pubmed: 23446552
Prog Mol Biol Transl Sci. 2012;105:151-209
pubmed: 22137432
Blood. 2005 Mar 15;105(6):2316-23
pubmed: 15550487
Thromb Haemost. 2014 Feb;111(2):226-32
pubmed: 24136406
N Engl J Med. 2009 Oct 22;361(17):1671-5
pubmed: 19846852
Thromb Res. 2011 Dec;128(6):603
pubmed: 21802712
Hum Gene Ther Clin Dev. 2015 Mar;26(1):5-14
pubmed: 25675273
Blood. 2008 Oct 15;112(8):3234-41
pubmed: 18647957
Biotechnol Appl Biochem. 2011 Jul-Aug;58(4):243-9
pubmed: 21838798
Thromb Res. 2010 Aug;126(2):e165
pubmed: 20605624
Hum Genet. 1993 Jun;91(5):496-503
pubmed: 8314564
Protein Expr Purif. 2016 May;121:149-56
pubmed: 26802680
Blood. 2010 Jun 10;115(23):4678-88
pubmed: 20335222
Blood. 2015 Mar 5;125(10):1553-61
pubmed: 25568350
JCI Insight. 2019 Jun 20;5:
pubmed: 31219805
Haemophilia. 2014 Jul;20(4):e327-35
pubmed: 24811361
Blood. 2012 Nov 29;120(23):4521-3
pubmed: 22919027
PLoS One. 2020 Oct 28;15(10):e0240896
pubmed: 33112889
Thromb Haemost. 2013 Aug;110(2):244-56
pubmed: 23676890
FEBS Open Bio. 2019 Aug;9(8):1370-1378
pubmed: 31077577
Eur J Pediatr. 1999 Dec;158 Suppl 3:S97-104
pubmed: 10650845

Auteurs

Benjamin J Samelson-Jones (BJ)

Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Deparment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Philadelphia, PA; and.

Jonathan D Finn (JD)

Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA.

Leslie J Raffini (LJ)

Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Deparment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Elizabeth P Merricks (EP)

Department of Pathology and Laboratory Medicine and.
Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Rodney M Camire (RM)

Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Deparment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Philadelphia, PA; and.

Timothy C Nichols (TC)

Department of Pathology and Laboratory Medicine and.
Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Valder R Arruda (VR)

Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Deparment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Philadelphia, PA; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH